Cuprina Holdings (Cayman) Limited Class A ( (CUPR) ) just unveiled an update.
On May 8, 2025, Cuprina Holdings announced the successful closing of the sale of 450,000 additional Class A ordinary shares at $4.00 per share, following the full exercise of the underwriter’s over-allotment option from its initial public offering (IPO). This transaction raised the company’s total gross proceeds to $13.8 million, enhancing its financial position and potentially strengthening its market presence in the biomedical and biotechnology sectors.
More about Cuprina Holdings (Cayman) Limited Class A
Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company focused on developing and commercializing products for managing chronic wounds and infertility, as well as cosmeceuticals in the health and beauty sector. The company leverages its expertise in biomedical research to create wound care products that meet international standards.
Average Trading Volume: 346,039
For a thorough assessment of CUPR stock, go to TipRanks’ Stock Analysis page.